ArticleExperimental hematology & oncology2026

Emerging agents and regimens for myeloproliferative neoplasms: updates from ASH 2025 Annual Meeting.

Tiantian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.